Novel RCBTB1 variants causing later-onset non-syndromic retinal dystrophy with macular chorioretinal atrophy

Ophthalmic Genet. 2022 Jun;43(3):332-339. doi: 10.1080/13816810.2021.2023196. Epub 2022 Jan 20.

Abstract

Background: Variants in RCBTB1 were recently described to cause a retinal dystrophy with only eight families described to date and a predominant phenotype of macular atrophy and peripheral reticular degeneration. Here, we further evaluate the genotypic and phenotypic characteristics of biallelic RCBTB1-associated retinal dystrophy in a North American clinic population.

Methods: A retrospective analysis of genetic and clinical features was performed in individuals with biallelic variants in RCBTB1.

Results: Three unrelated individuals of French-Canadian descent with rare biallelic RCBTB1 variants were identified. All individuals shared a novel p.(Ser342Leu) missense variant; one patient was homozygous whereas the other two each possessed a second unique novel variant p.(Gln120*) and p.(Pro224Leu). All three had macula-predominant disease with symptom onset in the fifth decade of life.

Conclusion: This report adds to the genetic diversity of RCBTB1-associated disease. These cases confirm the later-onset, relative to many other retinal dystrophies, and macular focus of disease described in most cases to-date. They are thus a reminder of considering hereditary disease in the differential for later-onset macular atrophy.

Keywords: Macular atrophy; RCBTB1; retinal dystrophy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Atrophy
  • Canada / ethnology
  • Guanine Nucleotide Exchange Factors / genetics
  • Humans
  • Macular Degeneration* / genetics
  • Pedigree
  • Phenotype
  • Retinal Dystrophies* / diagnosis
  • Retinal Dystrophies* / genetics
  • Retrospective Studies

Substances

  • Guanine Nucleotide Exchange Factors
  • RCBTB1 protein, human